Search

Search Constraints

You searched for: Author/Creator Boland, Brigid S.

Search Results

1. A Non‐Invasive Serological Test to Assess the Efficacy of Biologic and Non‐Biologic Therapies on the Mucosal Health of Patients With Crohn's Disease: 727. (October 2017)

2. Association of Ustekinumab Concentrations Using Anser® UST Mobility Shift Assay and Clinical Response in Crohn's Disease: 711. (October 2017)

3. Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. (November 2020)

4. Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. (November 2020)

5. Correction: Vedolizumab for Ulcerative Colitis. (April 2019)

6. Development and Validation of a Multi‐marker Serum Test for the Assessment of Mucosal Healing in Crohn's Disease Patients: 600. (October 2017)

7. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. (7th October 2022)

8. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease. Issue 11 (24th April 2020)

9. Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Issue 10 (27th September 2020)

10. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (May 2019)